The shares have been falling since the end of May and are now almost back to where they began at £3.95.
More: continued here
The shares have been falling since the end of May and are now almost back to where they began at £3.95.
More: continued here
Alliance Pharma said its investors would receive 62.5p per share under the deal DBAY believes …